home
portfolio
team
careers
contact
investor portal
home
portfolio
team
careers
contact
investor portal
Nextech Invest
Kura Oncology Announces New Patent for Tipifarnib in Hematologic Malignancies
Kura Oncology Announces New Patent for Tipifarnib in Hematologic Malignancies
Post navigation
Previous Post
Previous
Kura Oncology to Report First Quarter 2018 Financial Results
Next Post
Next
Kura Oncology Reports First Quarter 2018 Financial Results and Provides Corporate Update